Literature DB >> 28862745

Diagnostic exome sequencing in early-onset Parkinson's disease confirms VPS13C as a rare cause of autosomal-recessive Parkinson's disease.

B Schormair1,2, D Kemlink3, B Mollenhauer4,5, O Fiala3,6, G Machetanz4, J Roth3, R Berutti7, T M Strom2,7, B Haslinger8, C Trenkwalder4, D Zahorakova9, P Martasek9, E Ruzicka3, J Winkelmann1,2,8,10.   

Abstract

Parkinson's disease (PD) is a genetically heterogeneous disorder and new putative disease genes are discovered constantly. Therefore, whole-exome sequencing could be an efficient approach to genetic testing in PD. To evaluate its performance in early-onset sporadic PD, we performed diagnostic exome sequencing in 80 individuals with manifestation of PD symptoms at age 40 or earlier and a negative family history of PD. Variants in validated and candidate disease genes and risk factors for PD and atypical Parkinson syndromes were annotated, followed by further analysis for selected variants. We detected pathogenic variants in Mendelian genes in 6.25% of cases and high-impact risk factor variants in GBA in 5% of cases, resulting in overall maximum diagnostic yield of 11.25%. One individual was compound heterozygous for variants affecting canonical splice sites in VPS13C, confirming the causal role of protein-truncating variants in this gene linked to autosomal-recessive early-onset PD. Despite the low diagnostic yield of exome sequencing in sporadic early-onset PD, the confirmation of the recently discovered VPS13C gene highlights its advantage over using predefined gene panels.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Parkinson disease; VPS13C; exome; genetic testing

Mesh:

Substances:

Year:  2018        PMID: 28862745     DOI: 10.1111/cge.13124

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  30 in total

1.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

Review 2.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

Review 3.  Role of VPS13, a protein with similarity to ATG2, in physiology and disease.

Authors:  Berrak Ugur; William Hancock-Cerutti; Marianna Leonzino; Pietro De Camilli
Journal:  Curr Opin Genet Dev       Date:  2020-06-18       Impact factor: 5.578

Review 4.  Role of the endolysosomal system in Parkinson's disease.

Authors:  D J Vidyadhara; John E Lee; Sreeganga S Chandra
Journal:  J Neurochem       Date:  2019-07-31       Impact factor: 5.372

Review 5.  XK-Associated McLeod Syndrome: Nonhematological Manifestations and Relation to VPS13A Disease.

Authors:  Kevin Peikert; Andreas Hermann; Adrian Danek
Journal:  Transfus Med Hemother       Date:  2022-01-25       Impact factor: 3.747

6.  Identification of a large homozygous VPS13C deletion in a patient with early-onset Parkinsonism.

Authors:  Hossein Darvish; Paloma Bravo; Abbas Tafakhori; Luis J Azcona; Sakineh Ranji-Burachaloo; Amir Hossein Johari; Coro Paisán-Ruiz
Journal:  Mov Disord       Date:  2018-11-19       Impact factor: 10.338

7.  Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects.

Authors:  Eunju Seong; Ryan Insolera; Marija Dulovic; Erik-Jan Kamsteeg; Joanne Trinh; Norbert Brüggemann; Erin Sandford; Sheng Li; Ayse Bilge Ozel; Jun Z Li; Tamison Jewett; Anneke J A Kievit; Alexander Münchau; Vikram Shakkottai; Christine Klein; Catherine A Collins; Katja Lohmann; Bart P van de Warrenburg; Margit Burmeister
Journal:  Ann Neurol       Date:  2018-06-30       Impact factor: 10.422

8.  Utility and implications of exome sequencing in early-onset Parkinson's disease.

Authors:  Joanne Trinh; Katja Lohmann; Hauke Baumann; Alexander Balck; Max Borsche; Norbert Brüggemann; Leon Dure; Marissa Dean; Jens Volkmann; Sinem Tunc; Jannik Prasuhn; Heike Pawlack; Sophie Imhoff; Christina M Lill; Meike Kasten; Peter Bauer; Arndt Rolfs; Christine Klein
Journal:  Mov Disord       Date:  2018-12-10       Impact factor: 10.338

Review 9.  Genetic Testing for Parkinson Disease: Are We Ready?

Authors:  Lola Cook; Jeanine Schulze; Catherine Kopil; Tara Hastings; Anna Naito; Joanne Wojcieszek; Katelyn Payne; Roy N Alcalay; Christine Klein; Rachel Saunders-Pullman; Tatyana Simuni; Tatiana Foroud
Journal:  Neurol Clin Pract       Date:  2021-02

10.  Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.

Authors:  Uladzislau Rudakou; Eric Yu; Lynne Krohn; Jennifer A Ruskey; Farnaz Asayesh; Yves Dauvilliers; Dan Spiegelman; Lior Greenbaum; Stanley Fahn; Cheryl H Waters; Nicolas Dupré; Guy A Rouleau; Sharon Hassin-Baer; Edward A Fon; Roy N Alcalay; Ziv Gan-Or
Journal:  Brain       Date:  2021-03-03       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.